Information  X 
Enter a valid email address

TempletonEmerg.Mkt. (TEM)

  Print   

Friday 25 June, 2021

TempletonEmerg.Mkt.

2021 AGM - update on arrangements

RNS Number : 2215D
Templeton Emerging Markets IT PLC
25 June 2021
 

Stock Exchange Announcement

Templeton Emerging Markets Investment Trust PLC (the "Company")

2021 AGM - update on arrangements

Legal Entity Identifier 5493002NMTB70RZBXO96

 

As a result of the UK Government's announcement on 14 June 2021 regarding a delay in the lifting of COVID-19 restrictions, the Board regrets to inform shareholders that the 2021 AGM will now be held as a closed meeting, and shareholders will not be permitted to attend the AGM in person. Attendance will be limited to individuals necessary to form a quorum.

Shareholders are encouraged to submit proxy votes appointing the chairman of the meeting as their proxy to ensure that their vote counts. Proxy appointments must be received at the address specified in the notes to the notice of AGM by 12 noon on 6 July 2021. All valid proxy appointments received by this deadline will be included in the poll to be conducted at the AGM and the results of the poll will be announced in the usual way as soon as practicable following the conclusion of the meeting.

Shareholders are reminded that they may submit questions in advance of the AGM which will be considered and responses provided on www.temit.co.uk . Questions can be submitted by email to [email protected] or via www.temit.co.uk/investor/contact-us .

The health of our shareholders, directors and other stakeholders is very important to us and accordingly we strongly recommend that shareholders refrain from attending the AGM in person as entry will be refused.

 

Enquiries

 

For further information please e-mail [email protected] or contact Client Dealer Services at Franklin Templeton on free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors, or e-mail [email protected]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSELFIIEFSEIM

a d v e r t i s e m e n t